Lpl Financial LLC Moon Lake Immunotherapeutics Transaction History

Lpl Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$32.84 - $51.05 $82,395 - $128,084	-2,509 Reduced 28.36%	6,338 $299,000
Q1 2025 May 07, 2025	BUY	$36.75 - $54.34 $25,761 - $38,092	701 Added 8.61%	8,847 $345,000
Q4 2024 Feb 11, 2025	BUY	$45.84 - $57.91 $61,058 - $77,136	1,332 Added 19.55%	8,146 $432,000
Q3 2024 Nov 08, 2024	BUY	$40.15 - $55.4 $12,807 - $17,672	319 Added 4.91%	6,814 $343,000
Q2 2024 Aug 07, 2024	SELL	$38.43 - $48.6 $5,802 - $7,338	-151 Reduced 2.27%	6,495 $285,000

Q1 2024 May 10, 2024	SELL	$43.78 - $63.86 $27,143 - $39,593	-620 Reduced 8.53%	6,646 $333,000
Q4 2023 Feb 14, 2024	BUY	$36.35 - $63.02 $14,685 - $25,460	404 Added 5.89%	7,266 $438,000
Q3 2023 Nov 13, 2023	BUY	$48.35 - $61.26 $37,084 - $46,986	767 Added 12.58%	6,862 $391,000
Q2 2023 Jul 31, 2023	BUY	$19.01 - $51.79 $115,865 - $315,660	6,095 New	6,095 $310,000

181

38.5M

4.13M

1.51M

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $472M
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.